NovoCure competitorsClear all

NovoCure's top competitors include Lyell, Silverback Therapeutics, Sensei Biotherapeutics, Accuray, Zymeworks and Legend Biotech.
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background
NovoCure
NovoCure
NovoCure is a company engaged in the development, manufacture, and commercialization of solutions for the treatment of solid tumors.
Lyell
Lyell
Lyell Immunopharma is a T-cell reprogramming company to cure patients with solid tumors.
Silverback Therapeutics
Silverback Therapeutics
Silverback Therapeutics is a biotech company developing treatments for cancer, fibrosis, and infectious diseases.
Sensei Biotherapeutics
Sensei Biotherapeutics
Sensei Biotherapeutics (formerly known as Panacea Pharmaceuticals) is a biotechnology company developing biologics therapies targeting key components of the immune system for the treatment of cancers.
Accuray
Accuray
Accuray is a radiation oncology company that develops, manufactures, sells, and supports precise tumor treatment solutions.
Zymeworks
Zymeworks
Zymeworks is a computational biotechnology company focused on optimizing therapeutic antibodies and other protein-based therapeutics.
Legend Biotech
Legend Biotech
Legend Biotech is a biopharmaceutical company engaged in the discovery and development of cell therapies for oncology and other indications.
Founding Date
Founding Date
2000
Founding Date
2018
Founding Date
2016
Founding Date
1999
Founding Date
1990
Founding Date
2003
Founding Date
2014
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Saint Helier, JE HQ
München, DE
Haifa, IL
Chiyoda City, JP
Root, CH
Malvern, US
New York, US
see more
Locations
South San Francisco, US HQ
Bothell, US
Seattle, US
Locations
Seattle, US HQ
Locations
Rockville, US HQ
Boston, US
Locations
Sunnyvale, US HQ
Chengdu, CN
Hong Kong, HK
Tokyo, JP
Morges, CH
Madison, US
Locations
Vancouver, CA HQ
Seattle, US
Locations
Piscataway, US HQ
Nanjing, CN
Nanjing Shi, CN
Dublin, IE
Franklin Township, US
Franklin Township, US
Employees
Employees
1,02331% increase
Employees
188
Employees
52
Employees
25
Employees
9322% decrease
Employees
3839% increase
Employees
650
Valuation ($)
Valuation ($)
12.1 b
Valuation ($)
3.4 b
Valuation ($)
331.6 m
Valuation ($)
214.7 m
Valuation ($)
342.6 m
Valuation ($)
1.1 b
Valuation ($)
7.4 b
Twitter followers
Twitter followers
2 k
Twitter followers
N/A
Twitter followers
196
Twitter followers
158
Twitter followers
3.4 k
Twitter followers
1.1 k
Twitter followers
483
Number of tweets (last 30 days)
Number of tweets (last 30 days)
10
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
7
Number of tweets (last 30 days)
5
Number of tweets (last 30 days)
90
Number of tweets (last 30 days)
11
Number of tweets (last 30 days)
8
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
4.8
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
2.9
Average likes per tweet (last 30 days)
1.4
Average likes per tweet (last 30 days)
1
Average likes per tweet (last 30 days)
3.3
Average likes per tweet (last 30 days)
1
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
90%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
85.71%
Percentage of tweets with engagement (last 30 days)
80%
Percentage of tweets with engagement (last 30 days)
95.56%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
62.5%
Alexa Website Rank
Alexa Website Rank
297865
Alexa Website Rank
366493
Alexa Website Rank
282114
Alexa Website Rank
N/A
Alexa Website Rank
271337
Alexa Website Rank
412524
Alexa Website Rank
359227
Employee Rating
Employee Rating
4.1
Employee Rating
4
Employee Rating
3.1
Employee Rating
N/A
Employee Rating
4
Employee Rating
4.6
Employee Rating
3.8

Financial

Revenue (est.)
Revenue (est.)
$494.4m (FY, 2020)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$382.9m (FY, 2020)
Revenue (est.)
N/A
Revenue (est.)
$75.7m (FY, 2020)
Cost of goods
Cost of goods
$106.5m (FY, 2020)
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$233.2m (FY, 2020)
Cost of goods
N/A
Cost of goods
N/A
Gross profit
Gross profit
$387.9m (FY, 2020)
Gross profit
N/A
Gross profit
N/A
Gross profit
N/A
Gross profit
$149.7m (FY, 2020)
Gross profit
N/A
Gross profit
N/A
Net income
Net income
$19.8m (FY, 2020)
Net income
N/A
Net income
($24m) (FY, 2019)
Net income
($16.7m) (FY, 2019)
Net income
$3.8m (FY, 2020)
Net income
N/A
Net income
($303.5m) (FY, 2020)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 211m
Total funding raised
$ 28.5m
Total funding raised
N/A
Total funding raised
$ 125.9m
Total funding raised
$ 150.5m
For sources of this data, please see the company profile

View company profiles

Lyell
HQ
South San Francisco, US
Employees
188

Lyell Immunopharma is a T-cell reprogramming company to cure patients with solid tumors.

View company
Silverback Therapeutics
HQ
Seattle, US
Employees
52

Silverback Therapeutics is a biotech company developing treatments for cancer, fibrosis, and infectious diseases.

View company
Sensei Biotherapeutics
HQ
Rockville, US
Employees
25

Sensei Biotherapeutics (formerly known as Panacea Pharmaceuticals) is a biotechnology company developing biologics therapies targeting key components of the immune system for the treatment of cancers.

View company
Accuray
HQ
Sunnyvale, US
Employees
932↓ 2% decrease

Accuray is a radiation oncology company that develops, manufactures, sells, and supports precise tumor treatment solutions.

View company